- Home
- CUE vs JFU Comparison
CUE vs JFU Comparison
Compare CUE & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CUE | JFU |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.6M | 59.2M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CUE | JFU |
|---|---|---|
| Price | $0.30 | $6.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 9.2K |
| Earning Date | 11-12-2025 | 12-09-2022 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3110.57 |
| EPS | N/A | ★ 3.04 |
| Revenue | $7,100,000.00 | ★ $44,573,690.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $25.00 | N/A |
| P/E Ratio | ★ N/A | $2.02 |
| Revenue Growth | N/A | ★ 8.19 |
| 52 Week Low | $0.23 | $1.01 |
| 52 Week High | $1.54 | $9.48 |
Technical Indicators
Market Signals| Indicator | CUE | JFU |
|---|---|---|
| Relative Strength Index (RSI) | 38.47 | 48.42 |
| Support Level | $0.27 | $6.10 |
| Resistance Level | $0.37 | $7.48 |
| Average True Range (ATR) | 0.05 | 0.85 |
| MACD | 0.01 | -0.14 |
| Stochastic Oscillator | 23.35 | 38.00 |
Price Performance
Historical ComparisonAbout CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company's operations are organized into Material segments, consisting of E-commerce services, technology Empowerment service and Wealth Management services, of which it derives maximum revenue from technology Empowerment service. All its revenues are generated from the People's Republic of China.